Senior Regulatory Affairs Advisor &
Editorial Director of ATESSIA INTELLIGENCE

Doctor of Pharmacy
MSc in International Drug Development and Registration (Chatenay)
MSc in Health Management and Economics (Paris Dauphine)

After several years’ experience in the pharmaceutical industry in regulatory affairs (Sanofi), followed by 8 years in a renowned regulatory affairs consultancy (A.R.C. Pharma), Jeanne joined ATESSIA in 2018 as a senior consultant in healthcare product regulation and Editorial Director of ATESSIA INTELLIGENCE, (regulatory watch service,) and the firm’s Corporate Communications.

She leads the department, defining ATESSIA INTELLIGENCE’s regulatory watch editorial line, and ensures the impact analysis of essential regulatory news in an increasingly complex environment. Jeanne is specialized in the prospective monitoring of French and European legislative processes, and works to support customers in anticipating future regulatory requirements. She develops on-demand competitive intelligence offers.

Jeanne also provides regulatory advice, particularly on borderline health products and status changes (medicines, MDs, dietary supplements, cosmetics, biocides), the evolution of European pharmaceutical legislation, regulatory strategy on registrations, pharmaceutical responsibility of various types of establishments, early access to innovation in France, ethical anti-counterfeiting and transparency provisions, control of advertising media (GP/PM) and non-advertising media (institutional and environmental information) on behalf of pharmaceutical companies.



Regulatory monitoring



Early access to innovation

Project management

Regulatory strategy